Tech Company Financing Transactions

Immune Control Funding Round

Immune Control, based in West Conshohocken, secured $11.3 million from Anthem Capital, BioAdvance Ventures and Domain Associates.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

200 Barr Harbor Drive 450
West Conshohocken, PA 19428
USA

Phone

(610) 941-2928

Website

www.immunecontrol.com

Email Address

[email protected]

Overview

Immune Control, Inc. is a pharmaceutical company developing compounds for treatment of multiple myeloma and other immunological diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mark Strobeck

        

VP - Finance

Anne Shiflett

        

Browse more venture capital transactions:

Prev: 7/14/2005: Bradford Networks venture capital transaction
Next: 7/15/2005: Peptimmune venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary